Gene · 5476
Papers2,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cerebrospinal fluid sphingolipid and sterol metabolite profiles of neurologically normal subjects. | Mol Cell Biochem | 2025 | 40694316 | PubTator, text mining | PubMed |
| iVAE: an interpretable representation learning framework enhances clustering performance for single-cell data. | BMC Biol | 2025 | 40660220 | PubTator, text mining | PubMed |
| Research on CTSA-DeepLabV3+ Urban Green Space Classification Model Based on GF-2 Images. | Sensors (Basel) | 2025 | 40648121 | PubTator, text mining | PubMed |
| Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation. | J Clin Invest | 2025 | 40540388 | PubTator, text mining | PubMed |
Building on the Translational Science Benefits Model to include team science: a practical and theory-based approach to continuous quality improvement and impact evaluation for Clinical and Translational Science Award programs. | Front Public Health | 2025 | 40458088 | PubTator, text mining | PubMed |
| Narratives of Discovery as a catalyst for translational science education and training. | J Clin Transl Sci | 2025 | 40395391 | PubTator, text mining | PubMed |
| Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer. | Cancer Med | 2025 | 40377005 | PubTator, text mining | PubMed |
| Applications of the Cellular Thermal Shift Assay to Drug Discovery in Natural Products: A Review. | Int J Mol Sci | 2025 | 40362180 | PubTator, text mining | PubMed |
| Examining rural health equity and impact through the translational science benefits model: outcomes from the CTSA Consortium of Rural States (CORES). | Front Public Health | 2025 | 40356836 | PubTator, text mining | PubMed |
| Bombyx mori nuclear polyhedrosis virus infection regulated by host glycosphingolipids. | Pestic Biochem Physiol | 2025 | 40262890 | PubTator, text mining | PubMed |
| Glycosphingolipids as emerging attack points in bladder cancer. | Discov Oncol | 2025 | 40252176 | PubTator, text mining | PubMed |
| Navigating the road ahead: using concept mapping to assess Clinical and Translational Science Award (CTSA) program goals. | Front Public Health | 2025 | 40231183 | PubTator, text mining | PubMed |
| Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation. | Front Immunol | 2025 | 40226614 | PubTator, text mining | PubMed |
| Connecting the bibliographic-directed citation networks of translational research and implementation science. | J Clin Transl Sci | 2025 | 40201632 | PubTator, text mining | PubMed |
| Receptor modulated assembly and drug induced disassembly of amyloid beta aggregates at asymmetric neuronal model biomembranes. | Biophys Chem | 2025 | 40185057 | PubTator, text mining | PubMed |
| Novel CTSA Variant Identified in a Thai Family With Late-Infantile Galactosialidosis. | Ann Hum Genet | 2025 | 40165614 | PubTator, text mining | PubMed |
| Thieno[2,3-b]pyridines as a Novel Strategy Against Cervical Cancer: Mechanistic Insights and Therapeutic Potential. | Int J Mol Sci | 2025 | 40141292 | PubTator, text mining | PubMed |
| Protein Recognition of Glycosphingolipids in Membranes: Mechanistic and Quantitative Insights. | Anal Chem | 2025 | 40125709 | PubTator, text mining | PubMed |
| Exploring Single-Probe Single-Cell Mass Spectrometry: Current Trends and Future Directions. | Anal Chem | 2025 | 39999987 | PubTator, text mining | PubMed |
| Galactosialidosis: A Report of Three Cases Diagnosed With a Founder Genetic Mutation in the Bahraini Population. | Cureus | 2025 | 39981487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5476/papers?page=5